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Abstract
The proliferation, differentiation, and migration of keratinocytes are essential in the early
stages of wound healing. Hypoxia-Reoxygenation (H/R) injury to keratinocytes can occur in
various stressful environments such as surgery, trauma, and various forms of ulcers. The
effects of remifentanil on human keratinocytes under hypoxia-reoxygenation have not been
fully studied. Therefore, we investigated the effects of remifentanil on the proliferation, apo-
ptosis, and autophagic activation of human keratinocytes during hypoxic-reoxygenation.
Human keratinocytes were cultured under 1% oxygen tension for 24 h. The cells were then
treated with various concentrations of remifentanil (0.01, 0.1, 0.5, and 1 ng/mL) for 2 h.
Thereafter, the cells were reoxygenated for 12 h at 37°C. We measured cell viability via
MTT assay. Using quantitative real-time PCR and western blot analysis, we measured the
expression levels of proteins associated with apoptosis and autophagy. Quantification of
apoptotic cells was performed using flow cytometer analysis and autophagic vacuoles were
observed under a fluorescence microscope. Remifentanil treatment brought about an in-
crease in the proliferation of human keratinocytes damaged by hypoxia-reoxygenation
and decreased the apoptotic cell death, enhancing autophagic activity. However, the
autophagy pathway inhibitor 3-MA inhibited the protective effect of remifentanil in hypoxia-
reoxygenation injury. In conclusion, the current study demonstrated that remifentanil
treatment stimulated autophagy and reduced apoptotic cell death in a hypoxia-
reoxygenation model of human keratinocytes. Our results provide additional insights into
the relationship between apoptosis and autophagy.
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Introduction
Wound healing is important not only for repairing the skin but also for its beneficial effects on
systemic physiological defenses. Re-epithelialization initiated during the early stages of healing
is a critical factor in wound healing. This process includes the proliferation, differentiation, and
migration of keratinocytes to the wound margins [1,2].
Ischemia–reperfusion in skin can occur during various stressful environments such
assurgery and trauma. Pressure, diabetic, and varicose ulcers also can give rise to hypoxia-
reoxygenation injury of keratinocytes [3–5].
Apoptosis has a major role in the elimination of inflammatory cells and formation of granu-
lation tissue in the normal wound healing process. Apoptosis and autophagy in keratinocytes
are inevitable during ischemia-reperfusion, induced by skin injury [6].
Autophagy is a self-eating process that is important for balancing sources of energy at criti-
cal times during development and in the responses to stress. Autophagy also plays a crucial
role in removing damaged intracellular organelles and aggregated proteins as well as eliminat-
ing intracellular pathogens [6–8].
Remifentanil, an ultra-short-acting mu-opioid receptor agonist, is unique because of its es-
terase-based metabolism, minimal accumulation, and very rapid onset and offset of clinical ac-
tion. Remifentanil prevents the inflammatory response and suppressed inducible nitric oxide
synthase expression in septic mouse models [9]. After cardiopulmonary bypass coronary artery
surgery, remifentanil inhibited the release of biomarkers of myocardial damage [10]. However,
the effects of remifentanil on human keratinocytes and autophagy during hypoxia-reoxygena-
tion are yet to be fully studied. Here, we investigated the protective effect remifentanil confers
against hypoxia-reoxygenation injury in human keratinocytes and whether this effect is medi-
ated by autophagy.
Materials and Methods
1. Cell culture
Human keratinocytes (HaCaT cell line) were obtained from the American Type Culture Col-
lection (ATCC, Manassas,USA). Dulbecco's modified Eagle's medium (DMEM, GIBCO) sup-
plemented with 10% inactivated fetal bovine serum (FBS, GIBCO) containing 500 µg/mL
penicillin and 500 µg/mL streptomycin (GIBCO), was used to culture the cells at 37°C in a hu-
midified environment with 5% CO2. Media were changed once every 3 days.
2. Hypoxia/reoxygenation of cultured human keratinocytes and drug
treatment
The human keratinocytes were seeded in a 96-well plate (1 × 104 cells) before exposure to hyp-
oxia-reoxygenation. The cells were gassed with 94% N2, 5% CO2 and 1% O2 incubated for 24 h
at 37°C. After hypoxic condition, they were rapidly transferred into a normoxic incubator with
DMEM for reoxygenation. To determine whether the administration of remifentanil (Ultiva;
Glaxo Smith Kline Pharmaceuticals,UK) affects human keratinocytes in hypoxia-reoxygena-
tion injury, cells which were taken out from the hypoxic incubator were immediately exposed
to various concentrations of remifentanil (0.01, 0.1, 0.5, and 1 ng/mL) and normoxia for 2 h.
After remifentanil treatment, to simulate reoxygenation and recovery, the cells were reoxygen-
ated for 10 h at 37°C. Control group did not receive remifentanil treatment. Normoxia group
did not receive hypoxia or remifentanil treatment for 36 h. The 3-MA group was treated with
3-methyladenine (3-MA) for 1 h before remifentanil treatment and the NLX group was treated
with naloxone for 30 min before remifentanil treatment. (Fig. 1)
Remifentanil Protects Human Keratinocytes against HR Injury
PLOS ONE | DOI:10.1371/journal.pone.0116982 January 22, 2015 2 / 10
3. MTT assay
The viability of cultured cells was estimated by MTT assay (MTT, Amresco). In the MTT
assay, cells were placed in a 96-well plate and incubated for 24 h. After remifentanil treatment,
the cells were treated with 0.5 mg/ml of MTT in growth medium. Cell viability was measured
using an ELISA reader (Quant, Bio-Tek, Highland Park, USA) at 570 nm.
4. Flow cytometer analysis (with 1 ng/mL remifentanil treatment)
Measurement of apoptotic HaCaT cells was determined by Annexin V-FITC/PI staining. In
each group, the harvested cells were washed with PBS containing 1% bovine serum albumin and
centrifuged at 2,000 rpm for 10 min. The cells were resuspended in ice-cold 95% ethanol with
0.5% Tween 20. The fixed cells were washed in 1% BSA-PBS solution and then stained with 5
μL Annexin V–FITC and 5 μL propidium iodide (PI) (50 μg/mL). The results were expressed as
quadrant dot plots with intact phase (Annextin V-/PI-), early apoptotic phase (Annextin
V+/PI-), late apoptotic phase (Annextin V+/PI+) and necrotic phase (Annextin V-/PI+). Mean
expression of apoptotic and necrotic HaCaT cells were analyzed by flow cytometer. The number
of cells in each quadrant was expressed as percentages of total stained cells [11].
5. Hoechst staining (with 1 ng/mL remifentanil treatment)
After remifentanil pretreated, the cells were harvested onto a clean, fat-free glass slide with a
cytocentrifuge. They were stained in 4 μg/mL Hoechst 33342 for 10 min at 37°C in darkness
and washed twice in PBS. The slides were mounted with glycerol. The samples were observed
and photographed using epifluorescence microscopy (Carl Zeiss, Göettingen, Germany). The
number of cells showing condensed or fragmented nuclei was determined by a blinded observ-
er from a random sampling of 3 × 102 cells per experiment. Three independent experiments
were conducted.
6. Fluorescence microscopy (with 1 ng/mL remifentanil treatment)
Cells were grown on cover slips and treated with HS-1200. After 24 h, cells were stained with
0.05 mMMDC, a selective fluorescent marker for autophagic vacuoles, at 37°C for 1 h. The
changes in cellular fluorescence were observed using a microscope (Axioskop, Carl Zeiss,
Figure 1. The experimental protocols followed for all in vitro experiments are represented as follows.
Normoxia = normoxia group, Control = no remifentanil treatment group, RPT = remifentanil post treatment
group, 3-MA = both 3-MA and remifentanil treatment group, NLX = both naloxone and remifentanil
treatment group.
doi:10.1371/journal.pone.0116982.g001
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Germany). For further detection of the acidic cellular compartment, we used acridine orange,
which emits bright red fluorescence in acidic vesicles but emits green fluorescence in the
cytoplasm and nucleus. Cells were stained with 1 μg/mL acridine orange for 15 min and
washed with PBS. AVOs formation was observed using a LSM 700 confocal microscope (Carl
Zeiss, Germany).
7. Western blot analysis (with 1 ng/mL remifentanil treatment)
Cells were plated at a density of 2 x 106cells in 100 mm culture dishes. Cells treated with remi-
fentanil were washed twice with ice-cold PBS and centrifuged at 2,000 rpm for 10 min.
Total cell proteins were lysed with a RIPA buffer [300 mMNaCl, 50 mM Tris-HCl (Ph 7.6),
0.5% Triton100, 2Mm PMSF, 2 μg/ml aprotinin and 2 μg/ml leupeptin] and incubated at 4°C
for 30 min. The lysates were centrifuged at 14,000 rpm revolutions per min for 15 min at 4°C,
and sodium dodecyl sulfate (SDS) and sodium deoxycholicacid(0.2% final concentration) were
added. Protein concentrations of cell lysates were determined with Bradford protein assay
(Bio-Rad Richmond,CA USA) and BSA was used as a protein standard. A sample of 20 μg pro-
tein in each well was separated and it was loaded onto 7.5–15% SDS/PAGE.
The gels were transferred to Nitrocellulose membrane (Amersham GE Healthcare, Little
Chalfont, UK) and reacted with each antibody. Immunostaining with antibodes was performed
using Super Signal West Femto enhanced chemiluminescence substrate and detected with
Alpha Imager HP (Alpha Innotech, Santa Clara, USA). Equivalent protein loading was con-
firmed by Ponceau S staining. Antibodies used in the study were cleaved caspase-3 (1:1,000),
cleaved caspase-9 (1:1,000), Bcl-xl (1:1,000), Bax (1:1,000), LC3 (1:3,000), Becline-1 (1:1,000)
from Abcam and P62(1:1,000) and Atg5 (1:500) from Santa Cruz.
8. In vitro wound healing (with 1 ng/mL remifentanil treatment)
Cells were seeded into a cover glass for microscope slides in DMEM with 10% FBS. The conflu-
ent cell basal was scratched with an Eppendorf sterile pipette tip to steadily produce a circular
cell-free zone (1 mm in diameter) on the coverslips. The wound cultures were then incubated
at 37°C for 24 h, and wound healing process was observed under optical microscopy. After 24
h incubation in growth medium at 37°C, the new growth and migration into the cell-free zone
was considered as the process of in vitro healing. Images of the relatively healed monolayer
area were obtained and the pixel counts were analyzed using NIH Image J software.
Statistical analysis
All experiments were repeated five times. Multiple groups were compared using one-way anal-
ysis of variance (ANOVA) followed by a post hoc Turkey test. The data were expressed as
mean ± standard deviation (SD). P< 0.05 was considered as significant score (SPSS 13.0 Soft-
ware, SPSS Inc., Chicago, IL, USA).
Results
Effect of remifentanil treatment on cell viability
The cell viability rate (%) was calculated and compared with the control group. Control group
had lower cell viability than normoxia group. However, the cell viability was higher in the 0.01,
0.1, 0.5, and 1 ng/mL groups compared to the control group (P<0.05, Fig. 2A). In 3-MA
group, the cell viability was lower than that of the remifentanil groups (P<0.05, Fig. 2B).
Among all the concentrations, the cell viability was highest at 1 ng/mL remifentanil. Based
on this result, all subsequent experiments were performed with 1 ng/mL remifentanil.
Remifentanil Protects Human Keratinocytes against HR Injury
PLOS ONE | DOI:10.1371/journal.pone.0116982 January 22, 2015 4 / 10
Effects of remifentanil treatment on apoptosis
Annexin-V FITC/PI staining confirmed the anti-apoptotic effects of remifentanil quantitative-
ly (Fig. 3). The portion of annexin-V(+) cells in H/R and 3-MA groups increased by 46.9% and
55.2% (P< 0.05). However, remifentanil treatment significantly attenuated the percentage of
annexin-V(+) cells to 27.2% (P< 0.05), demonstrating the anti-apoptotic effect of remifenta-
nil.To ascertain the effect of remifentanil on apoptosis, Hoechst 33258 staining was used to de-
tect the cells under a fluorescence microscope (×400, Fig. 4). A majority of the cells in
normoxia, RPT and NLX groups showed normal morphology with round regular nuclei. In
contrast, apoptotic bodies were seen in control group and 3-MA group cells. However, remi-
fentanil treatment effectively prevented the apoptosis of cells as indicated by the morphological
analysis and the protective effect was not blocked by naloxone treatment. We also examined
the expression of factors associated with apoptosis in the cells subjected to H/R by western blot-
ting analysis. In RPT and NLX groups, cellular expression of cleaved caspase-3, 9, and BAX
were down-regulated while that of Bcl-xl was elevated (Fig. 5).
Effect of remifentanil treatment on the activation of autophagy
Significant accumulation of autophagic specific staining of MDC was observed around the nu-
clei in RPT and NLX groups cells (Fig. 6). Similarly, AO staining, indicated by red fluorescent
spots appeared in RPT and NLXgroups cells, while the normoxia, control, and 3-MA groups
showed mainly green cytoplasmic fluorescence (Fig. 7). We examined the activation of autop-
hagy related proteins in H/R-induced cells by western blotting analysis. ATG5, Becline-1, LC-3
Figure 2. The effect of remifentanil on cell viability in human keratinocytes assessed by MTT assay.
(A) Effect of remifentanil on HaCaT cells under H/R conditions assessed by MTT assay. *P< 0.05 as
compared with the control group.(B) Cell viability comparison between RPT and 3MA groups.*P< 0.05 as
compared with the RPT group.
doi:10.1371/journal.pone.0116982.g002
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II, and P62 were elevated in RPT and NLX groups. However, the protein levels decreased when
autophagy was suppressed by 3-MA (Fig. 8).
Effects of remifentanil treatmenton cell migration
The in vitromodel of wound healing was used to examine the effects of remifentanil on wound
healing(Fig. 9). In normoxia group, cells rapidly migrated to close the wound after 24 h.
However, in the control group and 3-MA group, there was a significant delay in healing
(p< 0.05), with decreased density. Cells treated with remifentanil exhibited faster migration
into the wounded area compared to the control group and 3-MA group cells (p< 0.05).
Figure 3. Detection of apoptosis and necrosis with Annexin-V-FITC and propidium iodide staining.
All the groups of cells with Annexin-V and propidium iodide staining were measured by flow cytometry.
Normoxia = normoxia group, Control = no remifentanil treatment group, RPT = remifentanil post treatment
group, 3-MA = both 3-MA and remifentanil treatment group.
doi:10.1371/journal.pone.0116982.g003
Figure 4. Hoechst staining: Morphological changes in H/R-induced HaCaT cells treated with
remifentanil (1ng/ml), 3-MA and naloxone. H/R-induced HaCaT cells treated with remifentanil, 3-MA and
naloxone as observed by fluorescence microscopy. Apoptotic bodies were seen in control and 3-MA group
cells. In contrast they were markedly reduced in RPT and NLX group cells. Normoxia = normoxia group,
Control = no remifentanil treatment group, RPT = remifentanil post treatment group, 3-MA = both 3-MA and
remifentanil treatment group, NLX = both naloxone and remifentanil treatment group.
doi:10.1371/journal.pone.0116982.g004
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Figure 6. MDC staining of cytoplasmic vacuoles after remifentanil treatment in human keratinocytes.
Fluorescence microscopic (×400) analysis of autophagosome in the H/R injured HaCaT cells. H/R caused
accumulation of autophagosomes containing partially digested cytoplasmic contents compared to the control
group. The remifentanilduring H/R dramatically increased formation of autophagosomes and the autophagy
pathway inhibitor 3-MA blocked formation of autophagosomes by remifentanil. But naloxone did not
block that.
doi:10.1371/journal.pone.0116982.g006
Figure 7. AO staining of autophagosomes after remifentanil treatment in human keratinocytes.
Fluorescence microscopic (×400) analysis of autophagosome in the H/R injured HaCaT cells. Stained with
acridine orange the green shows where the dye has stained the nucleus and the red is where the cell is
starting to’digest' parts of itself in small capsules called autophagasomes. H/R caused accumulation of
autophagosomes containing partially digested cytoplasmic contents compared to the control group. The
remifentanil during H/R dramatically increased formation of autophagosomes and the autophagy pathway
inhibitor 3-MA blocked formation of autophagosomes by remifentanil. But naloxone did not block that.
doi:10.1371/journal.pone.0116982.g007
Figure 5. Effects of remifentanil on the expression of caspase-3, caspase-9, Bcl-xl, and Bax in human
keratinocytes.Western blot analysis and densitometry. In RPT and NLX groups, cellular expression of
cleaved caspase-3, 9, and BAX were down-regulated while that of Bcl-xl was elevated. *P< 0.05 as
compared with the control group.
doi:10.1371/journal.pone.0116982.g005
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Discussion
The object of the current study is to determine the beneficial effect of remifentanil on human
keratinocytes in hypoxia-reoxygenation injury and to investigate whether autophagy is associ-
ated with the protective mechanism. This study provides four principal findings. First, we
showed that remifentanil treatment increased the proliferation of human keratinocytes in hyp-
oxia-reoxygenation injury (Fig. 2A). Second, remifentanil treatment protected human kerati-
nocytes against hypoxia-reoxygenation induced apoptosis. Using western blot analysis, we
showed that remifentanil treatment decreased cleaved caspase-3,-9 levels, related to caspase-de-
pendent pathway, and reduced Bax/Bcl-xl ratio, which is associated with mitochondrial related
pathway. Activation of the upstream regulators cleaved-caspase-3 and-9 is a key to the initiation
and induction of apoptosis [12,13]. It is known that the mitochondria-dependent apoptotic
pathway is regulated by Bcl-xl protein family, such as the anti-apoptotic protein Bcl-xl and pro-
apoptotic protein Bax, which are critical downstream regulators in caspase activation [14,15].
Figure 8. Effects of remifentanil on autophagy markers in human keratinocytes.Western blot analysis
and densitometry. ATG5, Becline-1, LC-3 II, and P62 were elevated in RPT and naloxone group cells.
*P< 0.05 as compared with the control group.
doi:10.1371/journal.pone.0116982.g008
Figure 9. In vitrowound healing.Remifentanil restored cell proliferation and migration, which had been
decreased by hypoxia. Investigation of cell migration capability after H/R was performed.Confluent
monolayers of HaCaT cells were wounded by scratching the surface as uniformly as possible with a 1 mL
pipette tip. *P< 0.05 as compared with the normoxia group.
doi:10.1371/journal.pone.0116982.g009
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Third, the anti-apoptotic effect of remifentanil treatment in human keratinocytes was prob-
ably due to the induction of intracellular autophagy. The intracellular autophagy pathway in-
hibitor 3-MA blocked the protective effect of remifentanil treatment on cellular apoptosis,
suggesting a key role for intracellular autophagy in remifentanil treatment. In autophagy-spe-
cific staining of MDC and AO, RPT group demonstrated more autophagic expression than
normoxia, control, and 3-MA groups. In the western blot analysis, we showed that remifentanil
treatment increased the expression of ATG5, Beclin-1, LC-3 II, and P62 proteins associated
with autophagy. We also demonstrated that protective effectthrough activation of autophagy
byremifentanil was not blocked by naloxone. This result suggests that an opioid-receptor sig-
naling does not mediate this effect.
ATG5 induces autophagy and is essential for autophagosome formation [16]. Beclin1 regu-
lates the kinase activity in the activation of mammalian Vps34, which is an initial step in vesicle
nucleation [17,18]. LC3-II is used as anautophagy marker because its lipidation and specific re-
cruitment of autophagosomes results in a shift from diffuse to punctate staining of the protein
and increases its electrophoretic mobility on gels compared with LC3-I [19]. p62/SQSTM1 is a
multifunctional adaptor protein that promotes the turnover of polyubiquitinated protein ag-
gregates through interaction with LC3 at the autophagosome [20,21].
Fourth, a wound-healing assay was performed to determine the migratory capability of
human keratinocytes. RPT group showed increased wound healing capability. Migration of
keratinocytes is a mandatory step in wound healing [22]. Diminished healing of keratinocytes
might lead to defective wound healing. The interaction between fibroblasts and keratinocytes is
important during wound healing. The expression of collagen can affect cell migration and ad-
hesion, and stimulate the metabolism of connective tissues [23].
Based on these results, we suggest that remifentanil treatment stimulated the endogenous
cellular protective effect in human keratinocytes against hypoxia-reoxygenation injury through
the activation of signaling pathways associated with autophagy. Previous studies have reported
the effect of autophagy against hypoxia-reoxygenation injury in other cells, but the effect of
remifentanil on autophagy in human keratinocytes with hypoxia-reoxygenation injury has not
been documented.
Conclusions
The present study shows that remifentanil treatment increases the human keratinocyte prolif-
eration rate and stimulates the expression of autophagy under hypoxia-reoxygenation injury.
No functional studies were performed to investigate the effects of remifentanil on wound heal-
ing process. Our results suggest that remifentanil may have a beneficial effect in the recovery of
wounds caused by hypoxia-reoxygenation injury.
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